Key for crossing the BBB with nanoparticles: the rational design

Scholarly Works

• Kumari, M.; Kumar, A.; Baldi, A. Drug delivery to brain: Formulation challenges and potential approaches. Novel Drug Delivery Systems in the management of CNS Disorders; Elsevier, 2025; pp 15–38. doi:10.1016/b978-0-443-13474-6.00027-5
• Pratap, G. K.; Poornima, D. V.; Vadlapudi, K.; Ruksana, F. Nanomedicine-Based Drug Delivery Systems for Treating Neurodegenerative Diseases. Encyclopedia of Green Materials; Springer Nature Singapore, 2024; pp 1454–1462. doi:10.1007/978-981-97-4618-7_149
• Tiwari, S.; Chaturvedi, S.; Kaul, A.; Choudhary, V.; Barthélémy, P.; Mishra, A. K. Development of amphiphilic self-assembled nucleolipid as BBB targeting probe based on SPECT. Discover nano 2024, 19, 210. doi:10.1186/s11671-024-04129-y
• Luo, W.; Chen, C.; Guo, X.; Guo, X.; Zheng, J.; Liu, J.; Fan, X.; Luo, M.; Yu, Z.; Li, H.; Liu, J.; Wang, Y. Critical Challenges of Intravenous Nanomaterials Crossing the Blood‐Brain Barrier: from Blood to Brain. Advanced Functional Materials 2024. doi:10.1002/adfm.202409522
• Yang, H.; Tan, H.; Wen, H.; Xin, P.; Liu, Y.; Deng, Z.; Xu, Y.; Gao, F.; Zhang, L.; Ye, Z.; Zhang, Z.; Chen, Y.; Wang, Y.; Sun, J.; Lam, J. W. Y.; Zhao, Z.; Kwok, R. T. K.; Qiu, Z.; Tang, B. Z. Recent Progress in Nanomedicine for the Diagnosis and Treatment of Alzheimer's Diseases. ACS nano 2024, 18, 33792–33826. doi:10.1021/acsnano.4c11966
• Chakraborty, B.; Patel, G.; Padhan, B.; Das, J.; Patel, M. Evolution of lipid nanoparticles as charioteers of Alzheimer's disease therapeutics. Applied Materials Today 2024, 41, 102442. doi:10.1016/j.apmt.2024.102442
• Hanumanthappa, R.; Parthasarathy, A.; Heggannavar, G. B.; PC, K.; Nanjaiah, H.; Kumbhar, R.; Devaraju, K. S. Recent advances in therapeutic strategies for Alzheimer's and Parkinson's disease using protein/peptide co‐modified polymer nanoparticles. Neuroprotection 2024, 2, 255–275. doi:10.1002/nep3.60
• Yao, Y.; Bei, F. Adeno-associated Virus-Mediated Gene Delivery Across the Blood-Brain Barrier. Advances in neurobiology 2024, 41, 91–112. doi:10.1007/978-3-031-69188-1_4
• de Moraes, B. P. T.; da Silva, K. P.; Paese, K.; Sinhorin, A. P.; Guterres, S. S.; Pohlmann, A. R.; Moraes-de-Souza, I.; de Oliveira Rodrigues, S.; SouzaSouza, K. F. C. E.; da Cunha, C. M. C.; de Almeida, M. A. P.; Bozza, P. T.; de Castro-Faria-Neto, H. C.; Silva, A. R.; Gonçalves-de-Albuquerque, C. F.; Ferrarini, S. R. Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malaria. Discover nano 2024, 19, 184. doi:10.1186/s11671-024-04121-6
• Chen, J.; Yang, W.-Z.; Chen, H.; Ding, X.; Chen, H.; Zhan, C.-H.; Jin, Z. Targeting protein aggregation: the promising application of polyoxometalates in neurodegenerative diseases. Inorganic Chemistry Frontiers 2024, 11, 7238–7255. doi:10.1039/d4qi01945h
• Rafati, N.; Zarepour, A.; Bigham, A.; Khosravi, A.; Naderi-Manesh, H.; Iravani, S.; Zarrabi, A. Nanosystems for targeted drug Delivery: Innovations and challenges in overcoming the Blood-Brain barrier for neurodegenerative disease and cancer therapy. International journal of pharmaceutics 2024, 666, 124800. doi:10.1016/j.ijpharm.2024.124800
• Ijaz, M.; Hasan, I.; Jiang, Z.; Ullah, Z.; Aslam, B.; Khurshid, M.; Sun, Y.; Guo, B. Combinatory Immunotherapy for Glioblastoma Treatment. Advanced Therapeutics 2024, 7. doi:10.1002/adtp.202400217
• Devi, C. M.; Deka, K.; Das, A. K.; Talukdar, A.; Sola, P. Recent Advances in Marine-Derived Nanoformulation for the Management of Glioblastoma. Molecular biotechnology 2024. doi:10.1007/s12033-024-01287-3
• Aminyavari, S.; Afshari, A. R.; Ahmadi, S. S.; Kesharwani, P.; Sanati, M.; Sahebkar, A. Unveiling the theranostic potential of SPIONs in Alzheimer's disease management. Journal of psychiatric research 2024, 179, 244–256. doi:10.1016/j.jpsychires.2024.09.022
• Teixeira, M. I.; Lopes, C. M.; Amaral, M. H.; Costa, P. C. Navigating Neurotoxicity and Safety Assessment of Nanocarriers for Brain Delivery: Strategies and Insights. Acta biomaterialia 2024, 189, 25–56. doi:10.1016/j.actbio.2024.09.027
• Kang, X.; Mita, N.; Zhou, L.; Wu, S.; Yue, Z.; Babu, R. J.; Chen, P. Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment. Pharmaceutics 2024, 16, 1228. doi:10.3390/pharmaceutics16091228
• López-Espinosa, J.; Park, P.; Holcomb, M.; Godin, B.; Villapol, S. Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review. Therapeutic delivery 2024, 15, 997–1024. doi:10.1080/20415990.2024.2401307
• Hameed, H.; Faheem, S.; Younas, K.; Jamshaid, M.; Ereej, N.; Hameed, A.; Munir, R.; Khokhar, R. A comprehensive review on lipid-based nanoparticles via nose to brain targeting as a novel approach. Journal of microencapsulation 2024, 41, 681–714. doi:10.1080/02652048.2024.2404414
• Sierri, G.; Patrucco, M.; Ferrario, D.; Renda, A.; Comi, S.; Ciprandi, M.; Fontanini, V.; Sica, F. S.; Sesana, S.; Costa Verdugo, M.; Kravicz, M.; Salassa, L.; Busnelli, M.; Re, F. Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine. Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology 2024, 16, e1991. doi:10.1002/wnan.1991
• Preethi, M.; Adhav, S.; Kursunge, H.; Borse, V. Introduction to Nanoparticles as a Potential Carrier for Brain Targeting. Application of Nanocarriers in Brain Delivery of Therapeutics; Springer Nature Singapore, 2024; pp 43–68. doi:10.1007/978-981-97-2859-6_3

Explore citations to this article at